429 related articles for article (PubMed ID: 32132005)
1. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; Eckardt KU; McMurray JJV; Weinrauch LA; Liu J; Claggett B; Lewis EF; Pfeffer MA
Diabetes Obes Metab; 2019 May; 21(5):1199-1208. PubMed ID: 30672083
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
4. Could metformin be used in patients with diabetes and advanced chronic kidney disease?
Chowdhury TA; Srirathan D; Abraham G; Oei EL; Fan SL; McCafferty K; Yaqoob MM
Diabetes Obes Metab; 2017 Feb; 19(2):156-161. PubMed ID: 27690331
[TBL] [Abstract][Full Text] [Related]
5. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
6. Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study.
Chen CC; Ko Y; Chen CH; Hung YJ; Wei TE; Chang TH; Ke SS; Kuo KN; Chen C
Am J Med Sci; 2022 Nov; 364(5):575-582. PubMed ID: 35483434
[TBL] [Abstract][Full Text] [Related]
7. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
Chang CH; Sakaguchi M; Dolin P
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
[TBL] [Abstract][Full Text] [Related]
9. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
[TBL] [Abstract][Full Text] [Related]
10. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
11. Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D; Takashi Y; Tanabe M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
[TBL] [Abstract][Full Text] [Related]
12. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
13. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
14. Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease.
Rahman F; Tuba S
Med Arch; 2022 Aug; 76(4):297-300. PubMed ID: 36313954
[TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases.
Pedrós C; Ávila M; Gómez-Lumbreras A; Manríquez M; Morros R;
BMC Nephrol; 2019 May; 20(1):193. PubMed ID: 31146690
[TBL] [Abstract][Full Text] [Related]
16. The Phantom of Metformin-Induced Lactic Acidosis in End-Stage Renal Disease Patients: Time to Reconsider with Peritoneal Dialysis Treatment.
Al-Hwiesh AK; Abdul-Rahman IS; Noor AS; Nasr-El-Deen MA; Abdelrahman A; El-Salamoni TS; Al-Muhanna FA; Al-Otaibi K; Al-Audah N
Perit Dial Int; 2017 1-2; 37(1):56-62. PubMed ID: 27680758
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
[TBL] [Abstract][Full Text] [Related]
18. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
Perkovic V; Toto R; Cooper ME; Mann JFE; Rosenstock J; McGuire DK; Kahn SE; Marx N; Alexander JH; Zinman B; Pfarr E; Schnaidt S; Meinicke T; von Eynatten M; George JT; Johansen OE; Wanner C;
Diabetes Care; 2020 Aug; 43(8):1803-1812. PubMed ID: 32444457
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
20. Metformin in chronic kidney disease: time for a rethink.
Heaf J
Perit Dial Int; 2014 Jun; 34(4):353-7. PubMed ID: 24711640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
